IGC Pharma unveils PRISM AI platform for Alzheimer's risk prediction
IGC Pharma has unveiled the PRISM AI platform, which aims to move Alzheimer's risk prediction toward brain-health intervention and commercial use. The announcement appeared on October 13.
Who is affected and how
- doctor
- For AI platforms that assess Alzheimer's risk, clinical validation should be requested separately.
Sources
- IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deploymenttradingview · Oct 13, 2026
- IGC Pharma Unveils PRISM AI Platform for Alzheimer’s Careaccessnewswire.com · Oct 13, 2026
- User | theeveningleader.com - IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deploymentbusiness.theeveningleader.com · Oct 13, 2026
- IGC Pharma Unveils PRISM, a Commercial AI Platform for Alzheimer’s Care and Research - IGC News - EveryTickereveryticker.com · Oct 14, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.